The TGF-β Family in Glioblastoma

Irene Golán-Cancela,Laia Caja
DOI: https://doi.org/10.3390/ijms25021067
IF: 5.6
2024-01-16
International Journal of Molecular Sciences
Abstract:Members of the transforming growth factor β (TGF-β) family have been implicated in the biology of several cancers. In this review, we focus on the role of TGFβ and bone morphogenetic protein (BMP) signaling in glioblastoma. Glioblastoma (GBM) is the most common malignant brain tumor in adults; it presents at a median age of 64 years, but can occur at any age, including childhood. Unfortunately, there is no cure, and even patients undergoing current treatments (surgical resection, radiotherapy, and chemotherapy) have a median survival of 15 months. There is a great need to identify new therapeutic targets to improve the treatment of GBM patients. TGF-βs signaling promotes tumorigenesis in glioblastoma, while BMPs suppress tumorigenic potential by inducing tumor cell differentiation. In this review, we discuss the actions of TGF-βs and BMPs on cancer cells as well as in the tumor microenvironment, and their use in potential therapeutic intervention.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the roles of members of the transforming growth factor -β (TGF -β) family in glioblastoma (GBM). Specifically, the paper focuses on the biological functions of TGF -β and bone morphogenetic protein (BMP) signaling pathways in glioblastoma, and how these signaling pathways affect the behavior of tumor cells and the tumor microenvironment (TME). The following are the main research directions of the paper: 1. **The role of TGF -β in glioblastoma**: - **Oncogenic effect**: In advanced glioblastoma, TGF -β acts as an oncogenic factor, promoting the proliferation, invasion, and self - renewal ability of tumor cells. High concentrations of TGF -β are associated with poor prognosis. - **Antitumor effect**: In early - stage tumors, TGF -β can inhibit cell proliferation, induce cell differentiation and apoptosis, and play an antitumor role. - **Regulation of TGF -β signaling pathway**: The paper discusses the regulatory effects of various deubiquitinating enzymes (such as USP15, USP2, USP26, USP4) on the TGF -β signaling pathway, and how these regulations affect the progression of glioblastoma. 2. **The role of BMPs in glioblastoma**: - **Tumor - suppressing effect**: In some cases, BMPs can inhibit the progression of glioblastoma by inducing the differentiation of tumor stem cells (GSCs), reducing cell proliferation, and increasing the expression of differentiation markers. - **Oncogenic effect**: In other cases, BMPs can also promote the proliferation, invasion, and self - renewal ability of tumor cells. The specific effect depends on the cell type and other factors in the tumor microenvironment. 3. **The role of TGF -β and BMPs in the tumor microenvironment**: - **Immune escape**: TGF -β promotes the immune escape of tumors by regulating the function of immune cells. - **Angiogenesis and metastasis**: TGF -β and BMPs are involved in the regulation of tumor angiogenesis and metastasis processes. 4. **Potential therapeutic interventions**: - The paper discusses how to use the regulatory mechanisms of TGF -β and BMPs signaling pathways to develop new treatment methods to improve the treatment effect of glioblastoma patients. In summary, this paper aims to comprehensively analyze the complex roles of TGF -β family members in glioblastoma and provide a scientific basis for finding new therapeutic targets.